Osteoarthritis, Knee
Conditions
Brief summary
In this study, the effects of 4-week aromatherapy massage on pain, functionality, sleep quality and menopausal symptoms will be examined in individuals diagnosed with knee osteoarthritis during menopause.
Detailed description
The aim of this study is to investigate the effect of aromatherapy massage performed with bergamot oil for 4 weeks on pain, function, sleep and menopausal symptoms in menopausal women with knee osteoarthritis. Participants will be randomly divided into 3 groups as Bergamot, placebo and control. In addition to the conventional treatment, the Bergamot group will receive 2 sessions of Bergamot oil per week for 4 weeks, and the placebo group will be massaged with 2 sessions of sweet almond oil for 4 weeks. the control group will continue conventional treatment for 4 weeks. All assessments will be performed before starting treatment and at the end of 4 weeks of treatment. Participants' pain will be evaluated by VAS, Functions by WOMAC, Sleep quality by PSQI, menopausal symptoms by Menopause Symptoms Evaluation scale. At the end of the study, the satisfaction of the participants will be evaluated with VAS.
Interventions
OTHERBergamot
The affected knee will be massaged with Bergamot oil for 4 weeks, 2 sessions per week.
OTHERPlacebo
The affected knee will be massaged with sweet almond oil for 4 weeks, 2 sessions per week.
Sponsors
KTO Karatay University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Being between the ages of 40-65, * having entered the menopause, * being diagnosed with knee OA, * being at the level of OA 2-3, * having pain at rest in the knee VAS ≥ 4.
Exclusion criteria
* Any knee surgery * known allergies to the oils to be used
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in pain at 4 weeks | Baseline and 4 weeks | The rest, activity and night pains of the participants will be evaluated with a 10 cm Visuak Analog Scale before the treatment and at the end of the 4-week application. 0 means no pain, 10 means excruciating pain. Results will be recorded in cm. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in function at 4 weeks | Baseline and 4 weeks | Participants' functions will be evaluated with Western Ontario and McMaster Universities Osteoarthritis Index. A minimum of 0 points and a maximum of 96 points can be obtained on the scale. High scores indicate high impairment and limitation of functional status and poor quality of daily life. Evaluations will be made before the study and after 4 weeks of practice. |
| Change from baseline in sleep quality at 4 weeks | Baseline and 4 weeks | The sleep quality of the participants will be evaluated with Pittsburgh Sleep Quality Index . The total score is between 0-21. High scores indicate poor sleep quality. Evaluations will be made before the study and after 4 weeks of practice. |
| Change from baseline in menopause symphtoms at 4 weeks | Baseline and 4 weeks | Participants' menopausal symptoms will be evaluated with the Menopause Symptoms Evaluation Scale. Higher scores indicate more menopausal symptoms. Evaluations will be made before the study and after 4 weeks of practice. |
| Patients satisfaction after the interventions | 4 weeks | Participants' satisfaction with the treatment over pain and function will be evaluated with Visual Analog Scale. Higher score indicate more satisfaction. Evaluation will take place after 4 weeks of study. |
Countries
Turkey (Türkiye)
Outcome results
None listed